Company Filing History:
Years Active: 2017-2025
Title: Bonto Faburay: Innovator in Immunogenic Compositions
Introduction
Bonto Faburay is a notable inventor based in Manhattan, Kansas, recognized for his contributions to the field of immunogenic compositions. With a focus on reducing the incidence and severity of diseases associated with tick-borne pathogens, his work has significant implications for veterinary medicine and public health.
Latest Patents
Faburay holds 2 patents that showcase his innovative approaches. His latest patents include immunogenic compositions and methods of using them, which provide compositions and methods for reducing the incidence of and/or severity of diseases associated with tick-borne pathogens. These compositions comprise a recombinant antigenic protein subunit that has been glycosylated, with preferred subunits including the MAP1 protein, the p30-1 sequence, the p28-Omp19 protein, and the MSP4 protein. The administration of such compositions to animals in need offers protection against clinical signs of infection in susceptible animals. Another significant patent involves Rift Valley Fever Virus glycoproteins, Gn and Gc, detailing subunit vaccines containing these glycoproteins, including nucleic acids encoding them, host cells, vectors, and immunoreagents generated with the glycoproteins.
Career Highlights
Throughout his career, Faburay has been associated with prominent institutions, including the Kansas State University Research Foundation and the United States of America, as represented by the Secretary of Agriculture. His work has contributed to advancements in vaccine development and disease prevention.
Collaborations
Faburay has collaborated with esteemed colleagues such as Juergen A Richt and William C Wilson, enhancing the impact of his research through shared expertise and knowledge.
Conclusion
Bonto Faburay's innovative work in immunogenic compositions highlights his commitment to advancing health solutions for both animals and humans. His patents reflect a dedication to addressing critical health challenges through scientific innovation.